Related Experiment Video
Updated: May 15, 2025

07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
990
Prognostic Value of Single Nodal Zone Metastasis in Non-Small-Cell Lung Cancer-A Multi-Institutional Study
Samanta Nicosia1,2, Paraskevas Lyberis1,2, Stefano Rudella3
1Department of Surgical Sciences, University of Torino, Corso Dogliotti, 14, 10126 Torino, Italy.
Journal of Clinical Medicine
|May 14, 2025
Summary
The location of mediastinal lymph node involvement in non-small-cell lung cancer (NSCLC) significantly impacts patient prognosis. Lower zone involvement indicates a worse outcome, while upper and subcarinal zones suggest better survival rates.
Area of Science:
- Oncology
- Thoracic Surgery
Background:
- Mediastinal lymph node involvement is a critical prognostic factor in non-small-cell lung cancer (NSCLC).
- Single-zone nodal involvement in NSCLC may present varied prognostic implications.
Purpose of the Study:
- To investigate if the prognosis of NSCLC with single-zone lymph node involvement differs based on the specific lymph node zone affected.
- To identify distinct survival outcomes associated with different mediastinal lymph node stations in NSCLC.
Main Methods:
- Retrospective analysis of 135 NSCLC patients with single lymph node zone involvement who underwent anatomical resection.
- Statistical comparison of patient prognosis based on the location of lymph node involvement (upper, aorto-pulmonary, subcarinal, lower zones).
Main Results:
- Overall survival (OS) and relapse-free survival (RFS) varied significantly across different lymph node zones (p < 0.01).
- Lower zone involvement was associated with a worse prognosis, while upper and subcarinal zones showed better outcomes.
- Aorto-pulmonary (AP) zone involvement presented intermediate survival rates.
Conclusions:
- The anatomical location of lymph node metastasis is a significant prognostic indicator in NSCLC.
- Understanding nodal zone involvement can refine prognostication and guide personalized treatment strategies for NSCLC patients.
- This finding highlights the importance of precise staging for optimizing patient management and survival outcomes.

